AZ HB2033

Amends section 13-3401 (definitions) and 36-2512 (schedule I substances) of the Arizona Revised Statutes relating to controlled substances.

Adds new synthetic drugs to the definition of "dangerous drug," including new cannabimimetic substances (synthetic cannabinoids), hallucinogenic substances, and stimulants like fentanyl analogs and cathinone derivatives.

Adds specific new controlled substances to Schedule I, including W-15, W-18, MT-45, AH-7921, U-47700, ephenidine, isophenidine, lefetamine, and various indole/indazole carboxamide compounds.

Updates cannabimimetic substance definitions to include broader structural categories covering indole-3-carboxamide, indazole-3-carboxamide, 8-quinolinyl-indole/indazole carboxylates, and naphthalenyl-indole/indazole carboxylates.

Establishes Schedule I classification for etizolam and clarifies depressant drug provisions to include new synthetic substances designed to evade existing drug laws.